EGFR and COVID-19: Finally, IL-6, MAPK3, MAPK1, MAPK14, MAPK8, IL-1β, CCL2, EGFR, PPARG, and NOS2 were declared key targets of XFBD for COVID-19 (Wang et al., 2020).